Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $6.9 Million - $7.67 Million
33,000 Added 113.4%
62,100 $13.6 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $3.74 Million - $4.3 Million
18,900 Added 185.29%
29,100 $6.61 Million
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $2.16 Million - $2.46 Million
10,200 New
10,200 $2.46 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $7.13 Million - $8.71 Million
35,000 New
35,000 $8.24 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.